Thyroid hormone therapy for obesity and nonthyroidal illnesses: A systematic review

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 10, 2009, Pages 3663-3675

  Kaptein, Elaine M ^a,c   Beale, Elizabeth ^a   Chan, Linda S ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c GNH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ACUTE KIDNEY FAILURE; CALORIC RESTRICTION; CLINICAL TRIAL; CRITICAL ILLNESS; EUTHYROIDISM; HEART OUTPUT; HEART RATE; HORMONAL THERAPY; HUMAN; HYPERTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MORBIDITY; MORTALITY; OBESITY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; VASCULAR RESISTANCE; WEIGHT REDUCTION;

EID: 70349918179     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0899     Document Type: Review

References (83)

1. Adler SM, Wartofsky L 2007 The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am 36:657-672, vi
2. Kaptein EM 2005 The thyroid in nonthyroidal illness. European Thyroid Association. www.hotthyroidology.com
3. De Groot LJ 2006 Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin 22:57-86, vi
4. Peeters RP, Debaveye Y, Fliers E, Visser TJ 2006 Changes within the thyroid axis during critical illness. Crit Care Clin 22:41-55, vi (Pubitemid 43037109)
5. Moore R, Grant AM, Howard AN, Mills IH 1980 Treatment of obesity with triiodothyronine and a very-low-calorie liquid formula diet. Lancet 1:223-226 (Pubitemid 10207661)
6. Moreira-Andrés MN, Del Cañizo-Gómez FJ, Black EG, Hoffenberg R 1981 Long-term evaluation of thyroidal response to partial calorie restriction in obesity. Clin Endocrinol (Oxf) 15:621-626 (Pubitemid 12253561)
7. Burman KD, Wartofsky L, Dinterman RE, Kesler P, Wannemacher Jr RW 1979 The effect of T3 and reverse T3 administration on muscle protein catabolism during fasting as measured by 3-methylhistidine excretion. Metabolism 28:805-813 (Pubitemid 9247674)
8. Mier A, Brophy C, Wass JA, Besser GM, Green M 1989 Reversible respiratory muscle weakness in hyperthyroidism.AmRev Respir Dis 139:529-533
9. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Saccà L, Filetti S, Lombardi G, Perticone F 2000 Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 85: 4701-4705 (Pubitemid 32157655)
10. Brennan MD, Powell C, Kaufman KR, Sun PC, Bahn RS, Nair KS 2006 The impact of overt and subclinical hyperthyroidism on skeletal muscle. Thyroid 16:375-380
11. Faber J, Wiinberg N, Schifter S, Mehlsen J 2001 Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur J Endocrinol 145:391-396 (Pubitemid 32927063)
12. Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G 2003 Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88:3202-3211 (Pubitemid 36877495)
13. Moore R, Mehrishi JN, Verdoorn C, Mills IH 1981 The role of T3 and its receptor in efficient metabolisers receiving very-low-calorie diets. Int J Obes 5:283-286 (Pubitemid 11043054)
14. Límanová Z, Marek J, Kracmar P, Kratochvíl O, Kopecká J, Sonka J 1979 Effects of total fasting in obesewomen.III. Response of serum thyroid hormones to thyroxine and triiodothyronine administration. Endokrinologie 73:221-226
15. Hamilton MA, Stevenson LW, Fonarow GC, Steimle A, Goldhaber JI, Child JS, Chopra IJ, Moriguchi JD, Hage A 1998 Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol 81:443-447 (Pubitemid 28099535)
16. Bray GA 1969 Effect of diet and triiodothyronine on the activity of sn-glycerol-3-phosphate dehydrogenase and on the metabolism of glucose and pyruvate by adipose tissue of obese patients. J Clin Invest 48:1413-1422
17. Hesch RD, Hüsch M, Ködding R, Höffken B, Meyer T 1981 Treatment of dopamine-dependent shock with triiodothyronine. Endocr Res Commun 8:229-237
18. Pingitore A, Galli E, Barison A, Iervasi A, Scarlattini M, Nucci D, L'abbate A, Mariotti R, Iervasi G 2008 Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab 93:1351-1358
19. Burman KD, Smallridge RC, Jones L, Ramos EA, O'Brien JT, Wright FD, Wartofsky L 1980 Glucagon kinetics in fasting: physiological elevations in serum 3,5,3′-triiodothyronine increase the metabolic clearance rate of glucagon. J Clin Endocrinol Metab 51: 1158-1165 (Pubitemid 11225480)
20. Ferrer J, Diez-Ewald M, García R, Rubio L, Rodríguez-Iturbe B 1978 Effects of triiodothyronine on the anemia of chronic renal failure. Am J Hematol 5:139-143 (Pubitemid 9113350)
21. Bray GA, Raben MS, Londono J, Gallagher Jr TF 1971 Effects of triiodothyronine, growth hormone and anabolic steroids on nitrogen excretion and oxygen consumption of obese patients. J Clin Endocrinol Metab 33:293-300
22. Byerley LO, Heber D 1996 Metabolic effects of triiodothyronine replacement during fasting in obese subjects. J Clin Endocrinol Metab 81:968-976 (Pubitemid 26083955)
23. Welle SL, Campbell RG 1986 Decrease in resting metabolic rate during rapid weight loss is reversed by low dose thyroid hormone treatment. Metabolism 35:289-291
24. Lim VS, Tsalikian E, Flanigan MJ 1989 Augmentation of protein degradation by L-triiodothyronine in uremia. Metabolism 38:1210-1215 (Pubitemid 20015497)
25. Abraham RR, Densem JW, Davies P, Davie MW, Wynn V 1985 The effects of triiodothyronine on energy expenditure, nitrogen balance and rates of weight and fat loss in obese patients during prolonged caloric restriction. Int J Obes 9:433-442 (Pubitemid 16189470)
26. Wilson JH, Lamberts SW 1981 The effect of triiodothyronine on weight loss and nitrogen balance of obese patients on a very-lowcalorie liquid-formula diet. Int J Obes 5:279-282 (Pubitemid 11043053)
27. Gardner DF, Kaplan MM, Stanley CA, Utiger RD 1979 Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 300:579-584
28. Vignati L, Finley RJ, Hagg S, Aoki TT 1978 Protein conservation during prolonged fast: a function of triiodothyronine levels. Trans Assoc Am Physicians 91:169-179 (Pubitemid 9176857)
29. Carter JN, Eastman CJ, Corcoran JM, Lazarus L 1977 Effects of triiodothyronine administration in patients with chronic renal failure. Aust N Z J Med 7:612-616 (Pubitemid 8275141)
30. Carter WJ, Shakir KM, Hodges S, Faas FH, Wynn JO 1975 Effect of thyroid hormone on metabolic adaptation to fasting. Metabolism 24:1177-1183
31. Lamki L, Ezrin C, Koven I, Steiner G 1973 L-thyroxine in the treatment of obesity without increase in loss of lean body mass. Metabolism 22:617-622
32. Lim VS, Zavala DC, Flanigan MJ, Freeman RM 1987 Blunted peripheral tissue responsiveness to thyroid hormone in uremic patients. Kidney Int 31:808-814
33. Polikar R, Goy JJ, Schlapfer J, Lemarchand-Beraud T, Biollaz J, Magnenat P, Nicod P 1986 Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexes. Am J Cardiol 58:987-991 (Pubitemid 17175839)
34. Lim VS, Flanigan MJ, Zavala DC, Freeman RM 1985 Protective adaptation of low serum triiodothyronine in patients with chronic renal failure. Kidney Int 28:541-549 (Pubitemid 15248045)
35. Acker CG, Flick R, Shapiro R, Scantlebury VP, Jordan ML, Vivas C, Greenberg A, Johnson JP 2002 Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). Am J Transplant 2:57-61 (Pubitemid 36306808)
36. Hollingsworth DR, Amatruda Jr TT, Scheig R 1970 Quantitative and qualitative effects of L-triiodothyronine in massive obesity. Metabolism 19:934-945
37. Bray GA, Melvin KE, Chopra IJ 1973 Effect of triiodothyronine on some metabolic responses of obese patients. Am J Clin Nutr 26: 715-721
38. Límanová Z, Sonka J, Kratochvíl O, Wilczek H, Marek J 1981 Effects of total fasting in obese women. IV. Response of serum triiodothyronine (T3) and reverse triiodothyronine (rT3) to administered T3. Endokrinologie 77:70-78
39. Koppeschaar HP, Meinders AE, Schwarz F 1983 Metabolic responses in grossly obese subjects treated with a very-low-calorie diet with and without triiodothyronine treatment. Int J Obes 7:133-141
40. Koppeschaar HP, Meinders AE, Schwarz F 1983 The effect of a low-calorie diet alone and in combination with triiodothyronine therapy on weight loss and hypophyseal thyroid function in obesity. Int J Obes 7:123-131
41. Osburne RC, Myers EA, Rodbard D, Burman KD, Georges LP, O'Brian JT 1983 Adaptation to hypocaloric feeding: physiologic significance of the fall in serum T3 as measured by the pulse wave arrival time (QKd). Metabolism 32:9-13 (Pubitemid 13174304)
42. Pasquali R, Baraldi G, Biso P, Piazzi S, Patrono D, Capelli M, Melchionda N 1984 Effect of 'physiological' doses of triiodothyronine replacement on the hormonal and metabolic adaptation to shortterm semistarvation and to low-calorie diet in obese patients. Clin Endocrinol (Oxf) 21:357-367
43. Wolman SI, Sheppard H, Fern M, Waterlow JC 1985 The effect of tri-iodothyronine (T3) on protein turnover and metabolic rate. Int J Obes 9:459-463 (Pubitemid 16189473)
44. Koppeschaar HP, Meinders AE, Schwarz F 1985 Renal concentrating ability in obesity. Effect of modified fasting and the supplementation of T3, sodium chloride and carbohydrate. Metabolism 34: 1066-1072
45. Rozen R, Abraham G, Falcou R, Apfelbaum M 1986 Effects of a 'physiological' dose of triiodothyronine on obese subjects during a protein-sparing diet. Int J Obes 10:303-312 (Pubitemid 16011888)
46. Nair KS, Halliday D, Ford GC, Garrow JS 1989 Effect of triiodothyronine on leucine kinetics, metabolic rate, glucose concentration and insulin secretion rate during two weeks of fasting in obese women. Int J Obes 13:487-496 (Pubitemid 19221164)
47. Becker RA, Vaughan GM, Ziegler MG, Seraile LG, Goldfarb IW, Mansour EH, McManus WF, Pruitt Jr BA, Mason Jr AD 1982 Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 10:870-875
48. Brent GA, Hershman JM 1986 Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 63:1-8
49. Moruzzi P, Doria E, Agostoni PG, Capacchione V, Sganzerla P 1994 Usefulness of L-thyroxine to improve cardiacandexercise performance in idiopathic dilated cardiomyopathy. Am J Cardiol 73:374-378 (Pubitemid 24068204)
50. Moruzzi P, Doria E, Agostoni PG 1996 Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy. Am J Med 101:461-467 (Pubitemid 126335965)
51. Acker CG, Singh AR, Flick RP, Bernardini J, Greenberg A, Johnson JP 2000 A trial of thyroxine in acute renal failure. Kidney Int 57: 293-298 (Pubitemid 30227777)
52. Lu X, Huang J, Zhang X, Li X, Wang C, Zhang P, Chen Y 2003 Effects of thyroxine on cardiac function and lymphocyte β-adrenoceptors in patients with chronic congestive heart failure. Chin Med J (Engl) 116:1697-1700 (Pubitemid 38008243)
53. Sirlak M, Yazicioglu L, Inan MB, Eryilmaz S, Tasoz R, Aral A, Ozyurda U 2004 Oral thyroid hormone pretreatment in left ventricular dysfunction. Eur J Cardiothorac Surg 26:720-725 (Pubitemid 39273569)
54. GolombekSG2008 Nonthyroidal illness syndrome and euthyroid sick syndrome in intensive care patients. Semin Perinatol 32:413-418
55. Dimmick S, Badawi N, Randell T 2004 Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing cardiac surgery. Cochrane Database Syst Rev 3. CD004220. DOI: 10.1002/14651858.CD004220.pub2
56. Osborn DA, Hunt R 2007 Postnatal thyroid hormones for preterm infants with transient hypothyroxinemia Cochrane Database Syst Rev 1. CD005945. DOI: 10.1002/14651858.CD005945.pub2
57. Osborn DA, Hunt R 2007 Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 1. CD005948. DOI: 10.1002/14651858.CD005948.pub2
58. Osborn DA, Hunt R 2007 Postnatal thyroid hormones of respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 1. CD005946. DOI: 10.1002/14651858.CD005946.pub2
59. Novitzky D, Cooper DK, Barton CI, Greer A, Chaffin J, Grim J, Zuhdi N 1989 Triiodothyronine as an inotropic agent after open heart surgery. J Thorac Cardiovasc Surg 98:972-977
60. Novitzky D, Cooper DK, Swanepoel A 1989 Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery. Eur J Cardiothorac Surg 3:140-145
61. Teiger E, Menasché P, Mansier P, Chevalier B, Lajeunie E, Bloch G, Piwnica A 1993 Triiodothyronine therapy in open-heart surgery: from hope to disappointment. Eur Heart J 14:629-633 (Pubitemid 23170676)
62. Vavouranakis I, Sanoudos G, Manios A, Kalogeropoulou K, Sitaras K, Kokkinos C 1994 Triiodothyronine administration in coronary artery bypass surgery: effect on hemodynamics. J Cardiovasc Surg (Torino) 35:383-389
63. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K 1995 Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333:1522-1527
64. Bennett-Guerrero E, Jimenez JL, White WD, D'Amico EB, Baldwin BI, Schwinn DA 1996 Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 study group. JAMA 275:687-692
65. Klemperer JD, Klein IL, Ojamaa K, Helm RE, Gomez M, Isom OW, Krieger KH 1996 Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg 61:1323-1327 (Pubitemid 26150212)
66. Novitzky D, Fontanet H, Snyder M, Coblio N, Smith D, Parsonnet V 1996 Impact of triiodothyronine on the survival of high-risk patients undergoing open heart surgery. Cardiology 87:509-515 (Pubitemid 26329305)
67. Malik FS, Mehra MR, Uber PA, Park MH, Scott RL, Van Meter CH 1999 Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock. J Card Fail 5:31-37 (Pubitemid 29149086)
68. Mullis-Jansson SL, Argenziano M, Corwin S, Homma S, Weinberg AD, Williams M, Rose EA, Smith CR 1999 A randomized doubleblind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J Thorac Cardiovasc Surg 117:1128-1134 (Pubitemid 29270352)
69. Ott RA, Gutfinger DE, Alimadadian H, Miller M, Selvan A, Weinberg D, Hlapcich WL, Tanner TM 1999 Reduced postoperative atrial fibrillation using multidrug prophylaxis. J Card Surg 14:437-443 (Pubitemid 30737984)
70. Carrel T, Eckstein F, Englberger L, Mury R, Mohacsi P 2002 Thyronin treatment in adult and pediatric heart surgery: clinical experience and review of the literature. Eur J Heart Fail 4:577-582 (Pubitemid 35278508)
71. Magalhães AP, Gus M, Silva LB, Schaan BD 2006 Oral triiodothyronine for the prevention of thyroid hormone reduction in adult valvular cardiac surgery. Braz J Med Biol Res 39:969-978 (Pubitemid 44111065)
72. Ranasinghe AM, Quinn DW, Pagano D, Edwards N, Faroqui M, Graham TR, Keogh BE, Mascaro J, Riddington DW, Rooney SJ, Townend JN, Wilson IC, Bonser RS 2006 Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Circulation 114(1 Suppl): 1245-1250 (Pubitemid 44297158)
73. Spratt DI, Frohnauer M, Cyr-Alves H, Kramer RS, Lucas FL, Morton JR, Cox DF, Becker K, Devlin JT 2007 Physiological effects of nonthyroidal illness syndrome in patients after cardiac surgery. Am J Physiol Endocrinol Metab 293:E310-E315
74. Vohra HA, Bapu D, Bahrami T, Gaer JA, Satur CM 2008 Does perioperative administration of thyroid hormones improve outcome following coronary artery bypass grafting? J Card Surg 23:92-96
75. West S, King V, Carey TS, Lohr KN,McKoyN, Sutton SF, Lux L April 2002 Systems to rate the strength of scientific evidence. Evidence Report/Technology Assessment no. 47.AHRQPublication no. 02-E016. Rockville, MD: Agency for Healthcare Research and Quality
76. Kaptein EM, Hays MT, Ferguson DC 1994 Thyroid hormone metabolism. Acomparative evaluation. Vet Clin NorthAmSmallAnim Pract 24:431-466
77. Cooper H, Hedges LV 1994 Vote-counting procedure in meta-analysis. Chapter 14. New York: Russell Sage Foundation
78. Fieller EC 1940 The biological standardization of insulin. Suppl J Royal Statist Soc 7:1-64
79. Motulsky H 1995 Intuitive biostatistics. New York: Oxford University Press; 285-286
80. Motulsky H 2009 CI of a sum, difference, quotient or product. QuickCalcs: Online Calculators for Scientists. San Diego: Graph Pad Software
81. Biondi B, Cooper DS 2008 The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29:76-131 (Pubitemid 351252748)
82. Chopra IJ, Sabatino, L 2000 Nature and sources of circulating thyroid hormones. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott Williams and Wilkins; 121-135
83. Santini F, Pinchera A, Marsili A, Ceccarini G, Castagna MG, Valeriano R, Giannetti M, Taddei D, Centoni R, Scartabelli G, RagoT, Mammoli C, Elisei R, Vitti P 2005 Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab 90:124-127 (Pubitemid 40116644)